Advertisement

Benign Soft Tissue Tumors

  • Murray F. Brennan
  • Cristina R. Antonescu
  • Robert G. Maki
Chapter

Abstract

Lipomas are the most common benign neoplasm and usually arise in subcutaneous tissue. The trunk and proximal limbs are the most frequent sites. Although deep-seated benign lipomas do occur in the mediastinum or retroperitoneum, seemingly mature fatty neoplasms in the retroperitoneum should be considered well-differentiated (WD) liposarcoma. Most lipomas are solitary, soft, and painless and grow slowly; 2–3 % of patients have multiple lesions that are occasionally seen in a familial pattern.

Keywords

Malignant Peripheral Nerve Sheath Tumor Granular Cell Tumor Smooth Muscle Tumor Myxoid Liposarcoma Renal Angiomyolipoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Willen H, Akerman M, Dal Cin P, et al. Comparison of chromosomal patterns with clinical features in 165 lipomas: a report of the CHAMP study group. Cancer Genet Cytogenet. 1998;102(1):46–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Dal Cin P, Sciot R, Polito P, et al. Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas. Histopathology. 1997;31(3):222–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Prontera P, Stangoni G, Manes I, et al. Encephalocraniocutaneous lipomatosis (ECCL) in a patient with history of familial multiple lipomatosis (FML). Am J Med Genet A. 2009;149A(3):543–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Hu WG, Lai EC, Liu H, et al. Diagnostic difficulties and treatment strategy of hepatic angiomyolipoma. Asian J Surg. 2011;34(4):158–62.PubMedCrossRefGoogle Scholar
  5. 5.
    Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose ­tissue in adult humans. N Engl J Med. 2009;360(15):1509–17.PubMedCrossRefGoogle Scholar
  6. 6.
    Brennan MF, Lewis JJ. Diagnosis and management of soft tissue sarcoma. London: Martin Dunitz; 1998.Google Scholar
  7. 7.
    Dehio C. Molecular and cellular basis of bartonella pathogenesis. Annu Rev Microbiol. 2004;58:365–90.PubMedCrossRefGoogle Scholar
  8. 8.
    Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21): 1182–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992;326(22):1456–63.PubMedCrossRefGoogle Scholar
  10. 10.
    Buckmiller LM, Munson PD, Dyamenahalli U, et al. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope. 2010;120(4):676–81.PubMedCrossRefGoogle Scholar
  11. 11.
    Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2009;26(5):610–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Leonardi-Bee J, Batta K, O’Brien C, et al. Interventions for infantile haemangiomas (strawberry birthmarks) of the skin. Cochrane Database Syst Rev. 2011;5:CD006545.PubMedGoogle Scholar
  13. 13.
    Kammula US, Buell JF, Labow DM, et al. Surgical management of benign tumors of the liver. Int J Gastrointest Cancer. 2001;30(3):141–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol. 2001;112(4):851–62.PubMedCrossRefGoogle Scholar
  15. 15.
    Ip PP, Tse KY, Tam KF. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy. Adv Anat Pathol. 2010;17(2):91–112.PubMedCrossRefGoogle Scholar
  16. 16.
    Carter JM, O’Hara C, Dundas G, et al. Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient With “Neuroblastoma-like” schwannomatosis and a novel germline SMARCB1 mutation. Am J Surg Pathol 2012;36(1):154–60.Google Scholar
  17. 17.
    Enzinger FM. Intramuscular Myxoma; a review and follow-up study of 34 cases. Am J Clin Pathol. 1965;43:104–13.PubMedGoogle Scholar
  18. 18.
    Bossert T, Gummert JF, Battellini R, Richter M, Barten M, Walther T, Falk V, Mohr FW. Surgical experience with 77 primary cardiac tumors. Interact Cardiovasc Thorac Surg 2005;4(4):311–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Willems SM, Schrage YM, Baelde JJ, et al. Myxoid tumours of soft tissue: the so-called ­myxoid extracellular matrix is heterogeneous in composition. Histopathology. 2008;52(4): 465–74.PubMedCrossRefGoogle Scholar
  20. 20.
    Willems SM, Mohseny AB, Balog C, et al. Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix. J Cell Mol Med. 2009;13(7):1291–301.PubMedCrossRefGoogle Scholar
  21. 21.
    Steeper TA, Rosai J. Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol. 1983;7(5):463–75.PubMedCrossRefGoogle Scholar
  22. 22.
    Fine BA, Munoz AK, Litz CE, et al. Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist. Gynecol Oncol. 2001;81(1):120–2.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Murray F. Brennan
    • 1
  • Cristina R. Antonescu
    • 2
  • Robert G. Maki
    • 3
  1. 1.International Center & Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Department of PathologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  3. 3.Departments of Medicine Pediatrics, and OrthopaedicsMount Sinai School of MedicineNew YorkUSA

Personalised recommendations